biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Stern IR

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon Dec 11, 2022 7:45pm

135 Views

Post# 35165095

RE:RE:RE:Stern IR

So say I accept the fact that you were into BTI the way you state.

What real difference did you make??

I bought my first shares at 46 cents10 years plus or minus ago.

Paid as high as $1.78

Where are we now?

Did you make a difference? Well maybe but the only way myself as an investor can measure is through the share price!

As we all can see you failed miserably!

You can only hope things are about to change.

If things turn around all will be forgotten and you will be a hero!

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages